Company name: Poviva Tea
Description: Producer and distributor of medical cannabidiol (CBD) products intended to maximize their bioactivity in the human body. The company’s medical cannabidiol (CBD) products include cannabinoid infused teas, raw ingredients and consumer products derived from cannabis crops grown without any harmful chemicals, enabling food, beverage and pharmaceutical industries to get a range of quality bio-active products.
Year founded: 2014
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
State: British Columbia
Start up capital raised (USD Million):
Business status: Generating Revenue
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: Ms. Marian Washington and Dr. Michelle Reillo sold a 49% stake in the company to Lexaria Bioscience (PINX: LXRP) for $70,000 on October 25, 2017. The acquisition will enable the acquirer to expand its expertise in delivering Cannabidiol (CBD)-infused products.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 0.14
Last known valuation date: 25-Oct-2017